These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 551896)

  • 61. Central action of increased osmolality to support blood pressure in deoxycorticosterone acetate-salt rats.
    O'Donaughy TL; Qi Y; Brooks VL
    Hypertension; 2006 Oct; 48(4):658-63. PubMed ID: 16966581
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Digoxin amplifies the effects of deoxycorticosterone acetate (DOCA) in intact water-drinking rats: implications for the mechanism of DOCA hypertension?
    Li M; Martin A; Liu DT; Whitworth JA
    J Hypertens; 1994 May; 12(5):569-76. PubMed ID: 7930557
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Addition of indapamide to frusemide increases natriuresis and creatinine clearance, but not diuresis, in fluid overloaded ICU patients.
    Bihari S; Holt AW; Prakash S; Bersten AD
    J Crit Care; 2016 Jun; 33():200-6. PubMed ID: 26948252
    [TBL] [Abstract][Full Text] [Related]  

  • 64. 5-HT2B-receptor antagonist LY-272015 is antihypertensive in DOCA-salt-hypertensive rats.
    Watts SW; Fink GD
    Am J Physiol; 1999 Mar; 276(3):H944-52. PubMed ID: 10070078
    [TBL] [Abstract][Full Text] [Related]  

  • 65. ETA receptor blockade attenuates the hypertension but not renal dysfunction in DOCA-salt rats.
    Allcock GH; Venema RC; Pollock DM
    Am J Physiol; 1998 Jul; 275(1):R245-52. PubMed ID: 9688985
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A review of 10 years of experience with indapamide as an antihypertensive agent.
    Thomas JR
    Hypertension; 1985; 7(6 Pt 2):II152-6. PubMed ID: 4077233
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Indapamide: its action in animals and man (author's transl)].
    Campbell DB
    Schweiz Rundsch Med Prax; 1982 Feb; 71(7):275-81. PubMed ID: 7111212
    [No Abstract]   [Full Text] [Related]  

  • 68. Effects of the selective neutral endopeptidase inhibitor, retrothiorphan, on renal function and blood pressure in conscious normotensive Wistar and hypertensive DOCA-salt rats.
    Pham I; el Amrani AI; Fournié-Zaluski MC; Corvol P; Roques B; Michel JB
    J Cardiovasc Pharmacol; 1992 Dec; 20(6):847-57. PubMed ID: 1282584
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Effect of a methionine-supplemented diet on the blood pressure of Sprague-Dawley and deoxycorticosterone acetate-salt hypertensive rats.
    Robin S; Maupoil V; Laurant P; Jacqueson A; Berthelot A
    Br J Nutr; 2004 Jun; 91(6):857-65. PubMed ID: 15182389
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A preliminary controlled evaluation of the antihypertensive effect of indapamide.
    Turner P; Volans GN; Rogers HJ
    Curr Med Res Opin; 1977; 4(8):596-601. PubMed ID: 326495
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Vasopressin and sympathetic nervous functions both contribute to development and maintenance of hypertension in DOCA-salt rats.
    Takata Y; Yamashita Y; Takishita S; Fujishima M
    Clin Exp Hypertens A; 1988; 10(2):203-27. PubMed ID: 3370846
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Concurrent administration of aqueous Azadirachta indica (neem) leaf extract with DOCA-salt prevents the development of hypertension and accompanying electrocardiogram changes in the rat.
    Obiefuna I; Young R
    Phytother Res; 2005 Sep; 19(9):792-5. PubMed ID: 16220573
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Chronic angiotensin blockade with candesartan cilexetil in DOCA/salt hypertensive rats reduces cardiac hypertrophy and coronary resistance without affecting blood pressure.
    Fujita H; Takeda K; Miki S; Morimoto S; Kawa T; Uchida A; Itoh H; Nakata T; Sasaki S; Nakagawa M
    Hypertens Res; 1997 Dec; 20(4):263-7. PubMed ID: 9453261
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [A comparative study of C19 steroid-induced hypertension and deoxycorticosterone acetate (DOCA)-salt hypertension].
    Manabe R; Honda M; Hatano M
    Nihon Naibunpi Gakkai Zasshi; 1984 Nov; 60(11):1328-37. PubMed ID: 6526083
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Cardiac and vascular responses in deoxycorticosterone acetate-salt hypertensive rats.
    Brown L; Ooi SY; Lau K; Sernia C
    Clin Exp Pharmacol Physiol; 2000 Apr; 27(4):263-9. PubMed ID: 10779123
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The effect of treatment with low dose ACE inhibitor and/or diuretic on coronary microvasculature in stroke-prone spontaneously hypertensive rats.
    Rakusan K; Cicutti N; Maurin A; Guez D; Schiavi P
    Microvasc Res; 2000 Mar; 59(2):243-54. PubMed ID: 10684730
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Effects of salt and DOCA on hypothalamic and baroreflex control of blood pressure.
    Takeda K; Nakamura Y; Hayashi J; Kawasaki S; Nakata T; Oguro M; Sasaki S; Nakagawa M
    Clin Exp Hypertens A; 1988; 10 Suppl 1():289-99. PubMed ID: 3242995
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Cardiac sympathetic hyperinnervation in deoxycorticosterone acetate-salt hypertensive rats.
    Lee TM; Chen CC; Chang NC
    Clin Sci (Lond); 2012 Oct; 123(7):445-57. PubMed ID: 22507072
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Pharmacological properties of indapamide. Rationale for use in hypertension.
    Bataillard A; Schiavi P; Sassard J
    Clin Pharmacokinet; 1999; 37 Suppl 1():7-12. PubMed ID: 10491728
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Effects of SA7060, a novel dual inhibitor of neutral endopeptidase and angiotensin-converting enzyme, on deoxycorticosterone acetate-salt-induced hypertension in rats.
    Kuro T; Okahara A; Nose M; Ikuse T; Matsumura Y
    Biol Pharm Bull; 2000 Jul; 23(7):820-5. PubMed ID: 10919359
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.